Harbor Capital Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Buy
321
+4
+1% +$144 ﹤0.01% 914
2026
Q1
$8K Buy
317
+80
+34% +$1.89K ﹤0.01% 1046
2025
Q4
$6K Sell
237
-4
-2% -$106 ﹤0.01% 1114
2025
Q3
$7K Buy
+241
New +$6.53K ﹤0.01% 1085

Other funds holding ASTH

Harbor Capital Advisors's ASTH Position: Q2 2026 in Review

Harbor Capital Advisors increased its Astrana Health (ASTH) stake by 1.3% in Q2 2026, buying an estimated $144 and bringing the position to 321 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

Harbor Capital Advisors first reported a position in ASTH in Q3 2025 and has held it in 4 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Harbor Capital Advisors held 321 shares of Astrana Health worth $15K as of Q2 2026.
  • Harbor Capital Advisors bought 4 Astrana Health shares in Q2 2026, an estimated $144.
  • Astrana Health made up ﹤0.01% of Harbor Capital Advisors's portfolio in Q2 2026, its #914 holding.
  • Harbor Capital Advisors first reported a position in Astrana Health in Q3 2025 and has held it in 4 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.